ALDH2 and Hyperglycemia: Based on these data, we proposed a working model (Figure 8) predicting that ALDH2 O-GlcNAc modification was a key mechanism in hyperglycemia-exacerbated myocardial I/R injury and Alda-1 exhibited a potential therapeutic target for the treatment.